Stockholm - Delayed Quote SEK
Xvivo Perfusion AB (publ) (XVIVO.ST)
279.40
-0.40
(-0.14%)
At close: April 17 at 12:59:50 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
111,290
111,290
46,288
27,856
-12,059
Investing Cash Flow
-243,814
-243,814
-161,619
-197,624
-187,703
Financing Cash Flow
-10,902
-10,902
418,547
-6,842
234,611
End Cash Position
415,521
415,521
546,088
246,545
398,696
Capital Expenditure
--
--
-143,936
-130,946
-94,074
Issuance of Capital Stock
--
--
429,250
815
245,353
Repayment of Debt
--
--
--
--
-5,940
Repurchase of Capital Stock
--
--
--
-368
--
Free Cash Flow
111,290
111,290
46,288
-103,090
-106,133
12/31/2021 - 10/8/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CHY.DU ChemoMetec A/S
63.95
+0.55%
CHEMMc.XC
CEVI.ST CellaVision AB (publ)
150.00
-0.27%
0DZ0.IL ChemoMetec A/S
480.20
+0.04%
ACIXF Acarix AB (publ)
0.0277
0.00%
PAX.ST Paxman AB (publ)
67.20
-0.59%
ALNOV.PA Novacyt S.A.
0.4890
-2.20%
OSSD.ST OssDsign AB (publ)
13.94
-2.65%
ACARIX.ST Acarix AB (publ)
0.2395
+2.57%
SECT-B.ST Sectra AB (publ)
274.80
+0.15%